Metastatic breast cancer, also referred to as metastases, advanced breast cancer, secondary tumors, secondaries or stage IV breast cancer, is a stage of breast cancer where the breast cancer cells have spread to distant sites beyond the axillary lymph nodes. There is no cure for metastatic breast cancer;[1] there is no stage after IV.
Metastases can occur several years after the primary breast cancer, although it is sometimes diagnosed at the same time as the primary breast cancer or, rarely, before the primary breast cancer has been diagnosed.[2]
Metastatic breast cancer cells frequently differ from the preceding primary breast cancer in properties such as receptor status. The cells have often developed resistance to several lines of previous treatment and have acquired special properties that permit them to metastasize to distant sites. Metastatic breast cancer can be treated, sometimes for many years, but it cannot be cured.[2] Distant metastases are the cause of about 90% of deaths due to breast cancer.[3]
Breast cancer can metastasize anywhere in body but primarily metastasizes to the bone, lungs, regional lymph nodes, liver and brain, with the most common site being the bone.[4] Treatment of metastatic breast cancer depends on location of the metastatic tumors and includes surgery, radiation, chemotherapy, biological, and hormonal therapy.[5]
Typical environmental barriers in a metastatic event include physical (a basement membrane), chemical (reactive oxygen species or ROS, hypoxia and low pH) and biological (immune surveillance, inhibitory cytokines and regulatory extra-cellular matrix (ECM) peptides) components.[6] Organ-specific anatomic considerations also influence metastasis; these include blood-flow patterns from the primary tumor and the homing ability of cancer cells to certain tissues. The targeting by cancer cells of specific organs is probably regulated by chemo-attractant factors and adhesion molecules produced by the target organ, along with cell-surface receptors expressed by the tumor cells.
^John’s Hopkins. "Metastatic Breast Cancer". Hopkins medicine. Retrieved 6 January 2021.
^ ab"Secondary (metastatic) breast cancer". Breast Cancer Care. Retrieved 22 October 2013.
^Fouad TM, Kogawa T, Liu DD, Shen Y, Masuda H, El-Zein R, et al. (July 2015). "Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis". Breast Cancer Research and Treatment. 152 (2): 407–16. doi:10.1007/s10549-015-3436-x. PMC 4492876. PMID 26017070.
^Lee YT (July 1983). "Breast carcinoma: pattern of metastasis at autopsy". Journal of Surgical Oncology. 23 (3): 175–80. doi:10.1002/jso.2930230311. PMID 6345937. S2CID 21869121.
^"Metastatic cancer overview". Canadian Cancer Society. Retrieved 8 September 2014.
^Suva LJ, Griffin RJ, Makhoul I (September 2009). "Mechanisms of bone metastases of breast cancer". Endocrine-Related Cancer. 16 (3). Bioscientifica: 703–13. doi:10.1677/ERC-09-0012. PMC 2914697. PMID 19443538. Retrieved 15 January 2010.
and 28 Related for: Metastatic breast cancer information
up of abnormal breast cells, not of abnormal lung cells. The tumor in the lung is then called metastaticbreastcancer, not lung cancer. Metastasis is...
Breastcancer is a cancer that develops from breast tissue. Signs of breastcancer may include a lump in the breast, a change in breast shape, dimpling...
Breastcancermetastatic mouse models are experimental approaches in which mice are genetically manipulated to develop a mammary tumor leading to distant...
most efficacious in early stage breastcancer, while systemic therapy is generally justified in advanced and metastatic disease, or in diseases with specific...
needed] Inflammatory breastcancer is similar in many ways, both prognostically and treatment-wise, to late-stage or metastaticbreastcancer; it can be distinguished...
among others, is a medication for the treatment of advanced or metastaticbreastcancers. It was developed by Eli Lilly and it acts as a CDK inhibitor...
0 or stage I breastcancer. The 5-year relative survival rate drops to 22% for women with stage IV (metastatic) breastcancer. In cancer types with high...
study of vosilasarm, a small (n=22) phase 1 study in women with metastaticbreastcancer, was started in 2017 and completed in 2020, with results published...
order to block proliferation of breastcancer cells in vivo. Palbociclib is indicated in HR+, HER2- metastaticbreastcancer cells. Because CDK4/6 inhibition...
(HR)-positive metastaticbreastcancer in postmenopausal women with disease progression as well as HR-positive, HER2-negative advanced breastcancer in combination...
of metastaticbreastcancer with cryoablation, resulting in prolonged survival 1972 – UK and other European countries approve tamoxifen for breast cancer...
(LCIS). Stages 1–3 are within the breast or regional lymph nodes. Stage 4 is a metastaticcancer. Metastaticbreastcancer has a less favorable prognosis...
with unresectable or metastatic HER2-positive breastcancer who have received a prior anti-HER2-based regimen either in the metastatic setting, or in the...
D. Kidman, "A group cognitive behaviour therapy programme with metastaticbreastcancer patients" 8 (4) Psycho-Oncology (1999): 295–305 Sarah Edelman,...
Currently, the main indications for the drug are metastaticbreastcancer, non-small cell lung cancer (NSCLC), and head and neck squamous cell carcinoma...
drug conjugate used for the treatment of metastatic triple-negative breastcancer and metastatic urothelial cancer. The most common side effects include...
treatment of metastatic HER2-positive breastcancer; it also used in the same combination as a neoadjuvant in early HER2-positive breastcancer. Side effects...
epidermal growth factor receptor 2-negative locally advanced or metastaticbreastcancer with one or more PIK3CA/AKT1/PTEN-alterations, as detected by an...
emtansine was approved specifically for treatment of HER2-positive metastaticbreastcancer (mBC) in patients who have been treated previously with trastuzumab...
therapy for HER2-positive breastcancer. It is used for the treatment of patients with advanced or metastaticbreastcancer whose tumors overexpress HER2...
Endocrine therapy is a common treatment for estrogen receptor positive breastcancer. However, resistance to this therapy can develop, leading to relapse...
not cure) the cancer in settings in which the cancer has spread beyond the breast and localized lymph nodes. See metastaticbreastcancer. Combined therapies...
in all movies in all languages. She died in 2006 after battling metastaticbreastcancer. Srividya was born on 24 July 1953 in Madras, Tamil Nadu into a...
chemotherapy, hormone blockers, or lapatinib) for the treatment of metastaticbreastcancer.[clarification needed] The overall hazard ratios (HR) for overall...
Treatment for metastaticbreastcancer patients with tumors that overexpress the HER2 gene. Recently approved for adjuvant therapy for breastcancer. FDA also...
Global Information